Decreased expression of SPRED1 mRNA was confirmed in the 75 AML patients compared with the control group (0.660 ± 0.132 vs. 19.274 ± 13.599, p = 0.000, Supplementary Material 2). This evidence concerns the gene SPRED1 and acute myeloid leukemia.